Phase I and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer

被引：0
|
作者：
Rademaker-Lakhai, JM
Horenblas, S
Meinhardt, W
Stokvis, E
De Reijke, TM
Jimeno, JM
Lazaro, LL
Martin, JAL
Beijnen, JH
Schellens, JHM
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[3] Pharmamar SA, Madrid, Spain
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2003年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：469 / 469
页数：1
相关论文
共 50 条
  • [21] Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer
    Schilsky, Richard L.
    Geary, David
    Skoog, Linda
    Desai, Apurva A.
    Valickas, Joyce
    Chen, Bee-Lian
    Masson, Eric
    Laurent, Dirk
    Pendowski, Cynthia
    Vokes, Everett E.
    Ratain, Mark J.
    TARGETED ONCOLOGY, 2008, 3 (01) : 3 - 11
  • [22] Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer
    Buckner, Jan C.
    Forouzesh, Bahram
    Erlichman, Charles
    Hidalgo, Manuel
    Boni, Joseph P.
    Dukart, Gary
    Berkenblit, Anna
    Rowinsky, Eric K.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (03) : 334 - 342
  • [23] Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer
    Vigushin, DM
    Poon, GK
    Boddy, A
    English, J
    Halbert, GW
    Pagonis, C
    Jarman, M
    Coombes, RC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (02) : 111 - 117
  • [24] Phase I and pharmacokinetic study of vatalanib plus capecitabine in patients with advanced cancer
    Richard L. Schilsky
    David Geary
    Linda Skoog
    Apurva A. Desai
    Joyce Valickas
    Bee-Lian Chen
    Eric Masson
    Dirk Laurent
    Cynthia Pendowski
    Everett E. Vokes
    Mark J. Ratain
    Targeted Oncology, 2008, 3 : 3 - 11
  • [25] Phase I study of weekly liposome-encapsulated doxorubicin in patients with advanced, androgen-independent prostate cancer
    Flaherty, KT
    Malkowicz, SB
    Vaughn, DJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (02): : 136 - 139
  • [26] Docetaxel-ifosfamide combination chemotherapy in patients with metastatic hormone-refractory prostate cancer: A phase I pharmacokinetic study
    Hervonen, P
    Jekunen, A
    Lefebvre, P
    Kellokumpu-Lehtinen, P
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2003, 23 (01) : 1 - 7
  • [27] Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors
    Simonelli, Matteo
    Zucali, Paolo A.
    Lorenzi, Elena
    Rubino, Luca
    De Vincenzo, Fabio
    De Sanctis, Rita
    Perrino, Matteo
    Mancini, Luca
    Di Tommaso, Luca
    Rimassa, Lorenza
    Masci, Giovanna
    Zuradelli, Monica
    Suter, Matteo B.
    Bertossi, Monica
    Fattuzzo, Giuseppe
    Giordano, Laura
    Roncalli, Massimo G.
    Santoro, Armando
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (05) : 989 - 998
  • [28] Role of Octreoscan in advanced androgen deprivation refractory prostate cancer
    De Vincentis, G.
    Remediani, S.
    Calabrese, P.
    Calandri, E.
    Criscuoli, B.
    Gurciullo, I.
    Liberatore, M.
    Massa, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S130 - S130
  • [29] A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer
    Danny Rischin
    Lorraine K. Webster
    Michael J. Millward
    Guy C. Toner
    Sumith Nawaratne
    Vinod Ganju
    Prudence Francis
    James F. Bishop
    Investigational New Drugs, 1999, 17 : 73 - 80
  • [30] A phase I and pharmacokinetic study of paclitaxel and epirubicin in advanced cancer
    Rischin, D
    Webster, LK
    Millward, MJ
    Toner, GC
    Nawaratne, S
    Ganju, V
    Francis, P
    Bishop, JF
    INVESTIGATIONAL NEW DRUGS, 1999, 17 (01) : 73 - 80
12345